Please provide your email address to receive an email when new articles are posted on . Cryoballoon ablation was noninferior to radiofrequency ablation in patients with atrial fibrillation and HFrEF.

Please provide your email address to receive an email when new articles are posted on . The FDA granted a new indication to a cryoballoon ablation catheter that allows it to be used as a first-line ...

Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique, ...

Pulmonary-vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation (PFA) is a nonthermal ablation method with few adverse effects beyond the myocardium. Data ...

NICE, FRANCE — Prespecified secondary analyses from the FIRE and ICE trial show significantly fewer rehospitalizations and repeat ablations for patients with paroxysmal atrial fibrillation (PAF) ...

Atrial fibrillation, a rapid and irregular heartbeat, is putting a growing number of Americans at risk of heart failure and stroke, and in turn dramatically increasing the clinical and financial ...

The VersaCross™ Transseptal Solution is available in Pigtail and J-tip RF wire configurations. (CNW Group/Baylis Medical Company Inc.) TORONTO, Nov. 20, 2019 /PRNewswire/ - Baylis Medical announced ...

CLEVELAND — Researchers at Cleveland Clinic have found that using a certain ablation procedure as the first treatment for intermittent atrial fibrillation may be more effective than standard-of-care ...

Patients with symptomatic paroxysmal A-fib stand a better chance of being in sinus rhythm at 1 year if they undergo first-line catheter ablation with a cryoballoon rather than start antiarrhythmic ...

A search of the BCBSA Technology Evaluation Center website did not find any assessment on cryoablation for atrial fibrillation. The CA ACC was invited to provide an opinion on this technology and to ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--C2 Therapeutics today announced the initiation of its Coldplay III trial with treatment of the first patient at University Hospitals in northeast Ohio. The ...